Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus - Wikidata - thesis-toulmin - TriplyDB

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

http://www.wikidata.org/entity/Q34343906

about

CD40 in coronary artery disease: a matter of macrophages?High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms The influence of innate and adaptive immune responses on atherosclerosis Cardiovascular disease in lupus: insights and updates The Sphinx's riddle: cardiovascular involvement in autoimmune rheumatic disease Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice.Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammation Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?Cardiovascular involvement in autoimmune diseases.Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus.The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors.IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.Selective IgE deficiency and cardiovascular diseases.Vaccination to modulate atherosclerosis Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting.Combination of Azathioprine and Aminosalicylate Treatment Prevent Risk of Cardiovascular Disease in Women with Ulcerative Colitis by Reducing Inflammation.Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention Redox homeostasis, T cells and kidney diseases: three faces in the dark.Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade.Determinants of brachial-ankle pulse wave velocity in Chinese patients with rheumatoid arthritis.Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages.Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction.Neutrophil extracellular traps: a walk on the wild side of exercise immunology.Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.Mendelian Randomization for the Identification of Causal Pathways in Atherosclerotic Vascular Disease.Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study.Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all.Genetic variation associated with cardiovascular risk in autoimmune diseases Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis.Resveratrol Role in Autoimmune Disease-A Mini-Review.IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus.Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.Acute Coronary Syndrome in Patients With Inflammatory Bowel Diseases: The Plaque and the Thrombus.Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity.

P2860

Q26752784-25C54603-FC69-498D-A083-BCC48689E374 Q26774658-D6506DC2-3D26-4C73-B707-AD9356D2FEE6 Q27000370-673878FE-F63C-4B3E-9D12-4B8BFD9BBAE3 Q27016554-BDD219F1-21FB-4C55-9A44-E78D629FAE41 Q28069667-4F48B3A8-10D0-4469-822E-36C775CFBB80 Q30405805-F56368E1-79ED-4AFC-BF5F-22BD79C831AF Q30419941-00074433-9412-4163-8DEB-4DE0038A4ADE Q33607501-9010C6F8-6C13-4082-85B8-E2C2727B9F9C Q33799781-1B3F3C31-FD85-4959-B54A-4060C0320945 Q33891946-3B4C88F3-27D3-45BE-8D92-D95A859C9F85 Q34081242-15FE4CCF-8C1D-41AA-812D-F670E0C67D0F Q34098294-BC39AFC6-79D1-47C0-92C9-00B29514C870 Q34512225-791A9E6A-1991-4A8A-97F5-079165D5F7D2 Q35070231-352717F0-D59C-4E0C-8E9B-A73C951FE352 Q35121150-2EFC695B-0634-4992-9637-6D08806D41B1 Q35516115-303B7FED-AA29-4E35-9D9A-922054007A6D Q35600876-727F0524-DDBE-4746-A4AC-9CB4BB231082 Q35763883-67182EDD-4D73-4418-AEE2-370A79F2E743 Q35939519-68325ADB-7444-42E0-8585-B5655F3A3BC2 Q35998510-C1F384B1-43F9-4DAF-9AE4-CE39F7FD2D26 Q36482958-28A2C79D-976A-4EC7-BC9D-8752BFA61BCA Q36746012-733F753C-7CC6-405F-9C61-2DE136C08539 Q36990716-5A9B0A3C-503B-494B-A66D-A6E8EDC1451F Q37105384-16479550-C734-4060-933E-30A16F8BFD2A Q37197627-04094268-50F3-4152-9187-14E83DAE2A31 Q37330468-336EF95A-4A82-4089-83AC-78B10C21D7D7 Q37413355-F3BC2E98-EFB7-48B6-B778-74762BDB36A0 Q37541469-5D12A7B4-EA36-4A38-B8F6-68DE90ECAF28 Q38287683-C72C3B06-89EA-47F8-B772-820685844D44 Q38663003-4D029D75-2648-4974-A104-64F446EE984E Q38704885-4F06519A-7204-4AA9-914B-97BE53A40E5F Q40725518-D3ABAEF2-1E0A-4FFC-91A8-BD87EBBEC97D Q41856851-05492BE7-76B1-46FF-92F0-D0A5C1BC0676 Q42370776-24983FB1-1729-46F0-9F28-A2CBDD50D390 Q43407682-40FCA6E9-41D6-4EC4-B9B3-31254E62F548 Q47158536-4C5D2F48-47DC-4F58-AB4C-52F59D6B16B5 Q47806004-1CC7262A-F434-4C28-A872-934231609CCF Q49072554-83111AF5-ED08-439B-959A-9B4E044A1D73 Q49687500-9CB7406C-2C78-4C86-9467-31EDC0E20E39 Q51560974-A6FEB9E3-E768-41EA-AD9C-D5D544442FA6

P2860

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

http://www.wikidata.org/entity/Q34343906

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

@ast

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

@en

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

@nl

type

label

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

@ast

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

@en

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

@nl

prefLabel

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

@ast

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

@en

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

@nl

P1433

Q34343906-13657C06-1134-4131-8BB0-1BF2C98B831D

P1476

Q34343906-B89150BC-4DA6-4943-BAC5-8DFC970D92EE

P2093

Q34343906-519132C6-40A1-4DA5-9EF2-A799E2D84A29

Q34343906-C88E5C49-B136-4831-96D7-6F28AB47382A

P2860

Q34343906-055C1233-BE97-4762-BFE6-04865E5BBD27

Q34343906-06CAF9E3-B05B-4C35-90A5-924146995DFD

Q34343906-0AC3837A-E18E-4C98-8854-CD2E1CD5E9CF

Q34343906-0B5A4C97-A8CE-415F-98F2-934575D91983

Q34343906-104546D2-254B-4581-953A-8799D06727C9

Q34343906-11EB9E8B-4A8B-4704-B172-C630873DABE8

Q34343906-14CAD16A-AE6E-4868-B3A8-AB460C9E4410

Q34343906-171FECF7-223E-4A30-9374-1EDBB110BD3C

Q34343906-1AC9927E-312B-4F87-B3BB-E95966B74CEF

Q34343906-1D773B5C-699E-43EC-B994-C9F358B83937

P304

Q34343906-D0A7C7AE-90C0-41AC-A863-123DD702FBAE

P31

Q34343906-1DACF57B-3692-494B-A3DB-5F5916FD9A49

P356

Q34343906-8FEE4231-432D-408C-930B-C8F5DD26DAC5

P478

Q34343906-94FAE0CD-AB1A-4C89-88FD-AA28B0BA0EF9

P577

Q34343906-8ACA5AC5-5930-48CB-827F-C8A9DFB88FB5

P5875

Q34343906-104B8C39-42C5-46AD-9C29-15B1E71ADB4D

P698

Q34343906-092F1DCE-B846-44CB-BC3E-77A166977599

P921

Q34343906-27D269CA-B3E6-4BB1-B208-D6F5B17A885B

P932

Q34343906-F309A267-A333-4CAB-AB95-2A9EC5FBC4A3

P356

ANNUREV-MED-060911-090007

P1433

Annual Review of Medicine

P1476

Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus

@en

P2093

J Michelle Kahlenberg

http://www.w3.org/2001/XMLSchema#string

Mariana J Kaplan

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

Extracellular DNA traps promote thrombosis.

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases

Inflammation, atherosclerosis, and coronary artery disease

The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data.

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.

Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.

P304

249-263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1146/ANNUREV-MED-060911-090007

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231610685

http://www.w3.org/2001/XMLSchema#string

P698

23020882

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4198172

http://www.w3.org/2001/XMLSchema#string